{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:52:05Z","timestamp":1792122725018,"version":"4.4.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10735-026-10863-7","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:48:58Z","timestamp":1782715738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting metabolic reprogramming in HPV-associated oral squamous cell carcinoma: current advances, challenges, and clinical prospects"],"prefix":"10.1007","volume":"57","author":[{"given":"Anjali","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Shit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-4333","authenticated-orcid":false,"given":"Mausumi","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"10863_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0309700","volume":"19","author":"Y Aisu","year":"2024","unstructured":"Aisu Y, Oshima N, Hyodo F et al (2024) Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch. PLoS ONE 19:1\u201321. https:\/\/doi.org\/10.1371\/journal.pone.0309700","journal-title":"PLoS ONE"},{"key":"10863_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335. https:\/\/doi.org\/10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"10863_CR3","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.3390\/cimb46060370","volume":"46","author":"A Arizmendi-Izazaga","year":"2024","unstructured":"Arizmendi-Izazaga A, Navarro-Tito N, Jim\u00e9nez-Wences H et al (2024) Bioinformatics analysis reveals E6 and E7 of HPV 16 regulate metabolic reprogramming in cervical cancer, head and neck cancer, and colorectal cancer through the PHD2-VHL-CUL2-ELOC-HIF-1\u03b1 axis. Curr Issues Mol Biol 46:6199\u20136222. https:\/\/doi.org\/10.3390\/cimb46060370","journal-title":"Curr Issues Mol Biol"},{"key":"10863_CR4","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.3390\/ijms26136337","volume":"26","author":"PC Arriola Ben\u00edtez","year":"2025","unstructured":"Arriola Ben\u00edtez PC, Fusco M, Amorin R et al (2025) Unraveling the Role of Tumor-Infiltrating Immune Cells in Head and Neck Squamous Cell Carcinoma: Implications for Antitumor Immune Responses and Immunotherapy. Int J Mol Sci 26:6337. https:\/\/doi.org\/10.3390\/ijms26136337","journal-title":"Int J Mol Sci"},{"key":"10863_CR5","doi-asserted-by":"publisher","first-page":"BSR20221682","DOI":"10.1042\/BSR20221682","volume":"42","author":"AA-B Badawy","year":"2022","unstructured":"Badawy AA-B (2022) Tryptophan metabolism and disposition in cancer biology and immunotherapy. Biosci Rep 42:BSR20221682. https:\/\/doi.org\/10.1042\/BSR20221682","journal-title":"Biosci Rep"},{"key":"10863_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/ijms23020775","volume":"23","author":"V Boschert","year":"2022","unstructured":"Boschert V, Teusch J, M\u00fcller-Richter UDA et al (2022) PKM2 modulation in head and neck squamous cell carcinoma. Int J Mol Sci 23:775. https:\/\/doi.org\/10.3390\/ijms23020775","journal-title":"Int J Mol Sci"},{"key":"10863_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1242\/jcs.031682","volume":"122","author":"JK Brunelle","year":"2009","unstructured":"Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122:437\u2013441. https:\/\/doi.org\/10.1242\/jcs.031682","journal-title":"J Cell Sci"},{"key":"10863_CR8","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.3390\/jcm14207258","volume":"14","author":"T Buset","year":"2025","unstructured":"Buset T, Yanni A, Gerbaux M et al (2025) Biological anti-tumoral mechanisms of metformin in head and neck squamous cell carcinomas: a systematic review. J Clin Med 14:7258. https:\/\/doi.org\/10.3390\/jcm14207258","journal-title":"J Clin Med"},{"key":"10863_CR9","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.3390\/cancers17203386","volume":"17","author":"MO Cakir","year":"2025","unstructured":"Cakir MO, Selek M, Yilmaz B et al (2025) Exosomes in HPV-associated cancers: from biomarkers to engineered therapeutics. Cancers (Basel) 17:3386. https:\/\/doi.org\/10.3390\/cancers17203386","journal-title":"Cancers (Basel)"},{"key":"10863_CR10","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.3390\/cancers14215406","volume":"14","author":"LRC Castellano","year":"2022","unstructured":"Castellano LRC, Cruz SBSC, Hier M et al (2022) Implications and emerging therapeutic avenues of inflammatory response in HPV+ head and neck squamous cell carcinoma. Cancers (Basel) 14:5406. https:\/\/doi.org\/10.3390\/cancers14215406","journal-title":"Cancers (Basel)"},{"key":"10863_CR11","doi-asserted-by":"publisher","first-page":"118236","DOI":"10.1016\/j.lfs.2020.118236","volume":"258","author":"V Chandel","year":"2020","unstructured":"Chandel V, Raj S, Kumar P et al (2020) Metabolic regulation in HPV associated head and neck squamous cell carcinoma. Life Sci 258:118236. https:\/\/doi.org\/10.1016\/j.lfs.2020.118236","journal-title":"Life Sci"},{"key":"10863_CR12","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1200\/JCO.22.02625","volume":"41","author":"AK Chaturvedi","year":"2023","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM et al (2023) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 41:3081\u20133088. https:\/\/doi.org\/10.1200\/JCO.22.02625","journal-title":"J Clin Oncol"},{"key":"10863_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jnci\/djy207","volume":"111","author":"S Chaudhary","year":"2019","unstructured":"Chaudhary S, Ganguly K, Muniyan S et al (2019) Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. J Natl Cancer Inst 111:233\u2013244. https:\/\/doi.org\/10.1093\/jnci\/djy207","journal-title":"J Natl Cancer Inst"},{"key":"10863_CR14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1186\/s12885-023-11316-0","volume":"23","author":"BC Cho","year":"2024","unstructured":"Cho BC, Bra\u00f1a I, Cirauqui B et al (2024) Pembrolizumab plus epacadostat in patients with recurrent\/metastatic head and neck squamous cell carcinoma (KEYNOTE-669\/ECHO-304): a phase 3, randomized, open-label study. BMC Cancer 23:1254. https:\/\/doi.org\/10.1186\/s12885-023-11316-0","journal-title":"BMC Cancer"},{"key":"10863_CR15","doi-asserted-by":"publisher","first-page":"e00270","DOI":"10.1128\/mBio.00270-16","volume":"7","author":"L Cicchini","year":"2016","unstructured":"Cicchini L, Westrich JA, Xu T et al (2016) Suppression of antitumor immune responses by human papillomavirus through epigenetic downregulation of CXCL14. mBio 7:e00270\u2013e00216. https:\/\/doi.org\/10.1128\/mBio.00270-16","journal-title":"mBio"},{"key":"10863_CR16","doi-asserted-by":"publisher","unstructured":"Cleary RK, Cmelak AJ (2016) Evolving treatment paradigms for oropharyngeal squamous cell carcinoma. J Glob Oncol. https:\/\/doi.org\/10.1200\/JGO.2016.006304. :JGO.2016.006304","DOI":"10.1200\/JGO.2016.006304"},{"key":"10863_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/biom9080351","volume":"9","author":"A Cruz-Gregorio","year":"2019","unstructured":"Cruz-Gregorio A, Aranda-Rivera AK, Aparicio-Trejo OE et al (2019) E6 oncoproteins from high-risk human papillomavirus induce mitochondrial metabolism in a head and neck squamous cell carcinoma model. Biomolecules 9:351. https:\/\/doi.org\/10.3390\/biom9080351","journal-title":"Biomolecules"},{"key":"10863_CR19","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.4161\/cc.24092","volume":"12","author":"JM Curry","year":"2013","unstructured":"Curry JM, Tuluc M, Whitaker-Menezes D et al (2013) Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle 12:1371\u20131384. https:\/\/doi.org\/10.4161\/cc.24092","journal-title":"Cell Cycle"},{"key":"10863_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fonc.2018.00436","volume":"8","author":"JM Curry","year":"2018","unstructured":"Curry JM, Johnson J, Mollaee M et al (2018) Metformin clinical trial in HPV\u2009+\u2009and HPV- Head and neck squamous cell carcinoma: impact on cancer cell apoptosis and immune infiltrate. Front Oncol 8:436. https:\/\/doi.org\/10.3389\/fonc.2018.00436","journal-title":"Front Oncol"},{"key":"10863_CR20","doi-asserted-by":"publisher","first-page":"104972","DOI":"10.1016\/j.oraloncology.2020.104972","volume":"110","author":"M Cust\u00f3dio","year":"2020","unstructured":"Cust\u00f3dio M, Biddle A, Tavassoli M (2020) Portrait of a CAF: the story of cancer-associated fibroblasts in head and neck cancer. Oral Oncol 110:104972. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104972","journal-title":"Oral Oncol"},{"key":"10863_CR21","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.ijrobp.2024.01.163","volume":"118","author":"P Dalal","year":"2024","unstructured":"Dalal P, Gensterblum-Miller E, Gu W et al (2024) Integrative single-cell RNA-Seq, single cell ATAC-Seq, and spatial RNA-seq analysis of heterogeneity in HPV-related head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 118:e73\u2013e74. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.163","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"10863_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/15384047.2017.1310349","volume":"19","author":"M Di Domenico","year":"2018","unstructured":"Di Domenico M, Giovane G, Kouidhi S et al (2018) HPV epigenetic mechanisms related to oropharyngeal and cervix cancers. Cancer Biol Ther 19:850\u2013857. https:\/\/doi.org\/10.1080\/15384047.2017.1310349","journal-title":"Cancer Biol Ther"},{"key":"10863_CR25","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/1055-9965.EPI-21-0576","volume":"30","author":"RC Eldridge","year":"2021","unstructured":"Eldridge RC, Uppal K, Hayes DN et al (2021) Plasma metabolic phenotypes of HPV-associated vs smoking-associated head and neck cancer and patient survival. Cancer Epidemiol Biomarkers Prev 30:1858\u20131866. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0576","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10863_CR24","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.3390\/cancers15123184","volume":"15","author":"RC Eldridge","year":"2023","unstructured":"Eldridge RC, Qin ZS, Saba NF et al (2023) Unsupervised hierarchical clustering of head and neck cancer patients by pre-treatment plasma metabolomics creates prognostic metabolic subtypes. Cancers 15:3184. https:\/\/doi.org\/10.3390\/cancers15123184","journal-title":"Cancers"},{"key":"10863_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41416-018-0364-7","volume":"120","author":"JC Fleming","year":"2019","unstructured":"Fleming JC, Woo J, Moutasim K et al (2019) HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma. Br J Cancer 120:356\u2013367. https:\/\/doi.org\/10.1038\/s41416-018-0364-7","journal-title":"Br J Cancer"},{"key":"10863_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12943-024-02193-7","volume":"23","author":"M Gan","year":"2024","unstructured":"Gan M, Liu N, Li W et al (2024) Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy. Mol Cancer 23:273. https:\/\/doi.org\/10.1186\/s12943-024-02193-7","journal-title":"Mol Cancer"},{"key":"10863_CR149","doi-asserted-by":"publisher","unstructured":"Gillison ML, Akagi K, Xiao W, et al (2019) Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res 29:1\u201317 https:\/\/doi.org\/10.1101\/gr.241141.118","DOI":"10.1101\/gr.241141.118"},{"key":"10863_CR28","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","volume":"33","author":"ML Gillison","year":"2015","unstructured":"Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C (2015) Epidemiology of human papillomavirus\u2013positive head and neck squamous cell carcinoma. J Clin Oncol 33:3235\u20133242. https:\/\/doi.org\/10.1200\/JCO.2015.61.6995","journal-title":"J Clin Oncol"},{"key":"10863_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/mc.23831","volume":"64","author":"FA Gon\u00e7alves","year":"2025","unstructured":"Gon\u00e7alves FA, da Silva Bittencourt L, Barbosa S et al (2025) Energy metabolic profile in oral potentially malignant disorders and oral squamous cell carcinoma: a preliminary landscape of warburg effect in oral cancer. Mol Carcinog 64:126\u2013137. https:\/\/doi.org\/10.1002\/mc.23831","journal-title":"Mol Carcinog"},{"key":"10863_CR30","doi-asserted-by":"publisher","first-page":"1275270","DOI":"10.3389\/fimmu.2023.1275270","volume":"14","author":"X Gong","year":"2023","unstructured":"Gong X, Xiong J, Gong Y et al (2023) Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC. Front Immunol 14:1275270. https:\/\/doi.org\/10.3389\/fimmu.2023.1275270","journal-title":"Front Immunol"},{"key":"10863_CR31","doi-asserted-by":"publisher","first-page":"20180047","DOI":"10.1259\/bjr.20180047","volume":"92","author":"E-L G\u00f6ttgens","year":"2019","unstructured":"G\u00f6ttgens E-L, Ostheimer C, Span PN et al (2019) HPV, hypoxia and radiation response in head and neck cancer. Br J Radiol 92:20180047. https:\/\/doi.org\/10.1259\/bjr.20180047","journal-title":"Br J Radiol"},{"key":"10863_CR32","doi-asserted-by":"publisher","first-page":"76704","DOI":"10.18632\/oncotarget.12501","volume":"7","author":"C G\u00f6tz","year":"2016","unstructured":"G\u00f6tz C, Drecoll E, Straub M et al (2016) Impact of HPV infection on oral squamous cell carcinoma. Oncotarget 7:76704\u201376712. https:\/\/doi.org\/10.18632\/oncotarget.12501","journal-title":"Oncotarget"},{"key":"10863_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.semcancer.2022.02.002","volume":"86","author":"J Greene","year":"2022","unstructured":"Greene J, Segaran A, Lord S (2022) Targeting OXPHOS and the electron transport chain in cancer; molecular and therapeutic implications. Sem Cancer Biol 86:851\u2013859. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.002","journal-title":"Sem Cancer Biol"},{"key":"10863_CR34","doi-asserted-by":"publisher","first-page":"116906","DOI":"10.1016\/j.biopha.2024.116906","volume":"176","author":"S Guo","year":"2024","unstructured":"Guo S, Wang X, Wang Y et al (2024) The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma. Biomed Pharmacother 176:116906. https:\/\/doi.org\/10.1016\/j.biopha.2024.116906","journal-title":"Biomed Pharmacother"},{"key":"10863_CR35","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.21037\/tcr-2025-1019","volume":"14","author":"Y Guo","year":"2025","unstructured":"Guo Y, Wu X, Xu Y et al (2025) Identification and prognostic assessment of clonal and functional heterogeneity in head and neck squamous cell carcinoma. Transl Cancer Res 14:7758\u20137772. https:\/\/doi.org\/10.21037\/tcr-2025-1019","journal-title":"Transl Cancer Res"},{"key":"10863_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"10863_CR37","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1089\/ars.2011.4123","volume":"16","author":"DE Handy","year":"2012","unstructured":"Handy DE, Loscalzo J (2012) Redox regulation of mitochondrial function. Antioxid Redox Signal 16:1323\u20131367. https:\/\/doi.org\/10.1089\/ars.2011.4123","journal-title":"Antioxid Redox Signal"},{"key":"10863_CR38","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.oraloncology.2015.06.003","volume":"51","author":"E Hanns","year":"2015","unstructured":"Hanns E, Job S, Coliat P et al (2015) Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature. Oral Oncol 51:848\u2013856. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.06.003","journal-title":"Oral Oncol"},{"key":"10863_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/1535-7163.MCT-23-0794","volume":"24","author":"L Hayrapetyan","year":"2025","unstructured":"Hayrapetyan L, Roth SM, Quintin A et al (2025) HPV and p53 status as precision determinants of head and neck cancer response to DNA-PKcs inhibition in combination with irradiation. Mol Cancer Ther 24:214\u2013229. https:\/\/doi.org\/10.1158\/1535-7163.MCT-23-0794","journal-title":"Mol Cancer Ther"},{"key":"10863_CR40","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbrc.2020.09.134","volume":"533","author":"A H\u00e9mon","year":"2020","unstructured":"H\u00e9mon A, Louandre C, Lailler C et al (2020) SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck squamous cell carcinoma. Biochem Biophys Res Commun 533:1083\u20131087. https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.134","journal-title":"Biochem Biophys Res Commun"},{"key":"10863_CR41","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jamaoto.2022.2284","volume":"148","author":"SB Hobday","year":"2022","unstructured":"Hobday SB, Brody RM, Kriegsman B et al (2022) Outcomes among patients with mucosal head and neck squamous cell carcinoma treated with checkpoint inhibitors. JAMA Otolaryngol Head Neck Surg 148:918\u2013926. https:\/\/doi.org\/10.1001\/jamaoto.2022.2284","journal-title":"JAMA Otolaryngology\u2013Head Neck Surg"},{"key":"10863_CR42","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/ijc.33594","volume":"149","author":"K Hoppe-Seyler","year":"2021","unstructured":"Hoppe-Seyler K, Herrmann AL, D\u00e4schle A et al (2021) Effects of metformin on the virus\/host cell crosstalk in human papillomavirus-positive cancer cells. Int J Cancer 149:1137\u20131149. https:\/\/doi.org\/10.1002\/ijc.33594","journal-title":"Int J Cancer"},{"key":"10863_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12967-023-04263-8","volume":"21","author":"Y Hua","year":"2023","unstructured":"Hua Y, Zheng Y, Yao Y et al (2023) Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing. J Translational Med 21:403. https:\/\/doi.org\/10.1186\/s12967-023-04263-8","journal-title":"J Translational Med"},{"key":"10863_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cells7030021","volume":"7","author":"D Jia","year":"2018","unstructured":"Jia D, Park JH, Jung KH et al (2018) Elucidating the metabolic plasticity of cancer: mitochondrial reprogramming and hybrid metabolic States. Cells 7:21. https:\/\/doi.org\/10.3390\/cells7030021","journal-title":"Cells"},{"key":"10863_CR45","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1096\/fj.201802226R","volume":"33","author":"E Jiang","year":"2019","unstructured":"Jiang E, Xu Z, Wang M et al (2019) Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma. FASEB J 33:5690\u20135703. https:\/\/doi.org\/10.1096\/fj.201802226R","journal-title":"FASEB J"},{"key":"10863_CR46","doi-asserted-by":"publisher","first-page":"105975","DOI":"10.1016\/j.archoralbio.2024.105975","volume":"163","author":"F Jing","year":"2024","unstructured":"Jing F, Zhu L, Bai J et al (2024) A prognostic model built on amino acid metabolism patterns in HPV-associated head and neck squamous cell carcinoma. Arch Oral Biol 163:105975. https:\/\/doi.org\/10.1016\/j.archoralbio.2024.105975","journal-title":"Arch Oral Biol"},{"key":"10863_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/bjc.2012.568","volume":"108","author":"PV Jithesh","year":"2013","unstructured":"Jithesh PV, Risk JM, Schache AG et al (2013) The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 108:370\u2013379. https:\/\/doi.org\/10.1038\/bjc.2012.568","journal-title":"Br J Cancer"},{"key":"10863_CR48","doi-asserted-by":"publisher","first-page":"e00580","DOI":"10.1128\/mSphere.00580-17","volume":"3","author":"ME Johnson","year":"2018","unstructured":"Johnson ME, Cantalupo PG, Pipas JM (2018) Identification of head and neck cancer subtypes based on human papillomavirus presence and E2F-regulated gene expression. mSphere 3:e00580\u2013e00517. https:\/\/doi.org\/10.1128\/mSphere.00580-17","journal-title":"mSphere"},{"key":"10863_CR49","doi-asserted-by":"publisher","first-page":"51530","DOI":"10.18632\/oncotarget.17887","volume":"8","author":"Y-S Jung","year":"2017","unstructured":"Jung Y-S, Najy AJ, Huang W et al (2017) HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget 8:51530\u201351541. https:\/\/doi.org\/10.18632\/oncotarget.17887","journal-title":"Oncotarget"},{"key":"10863_CR50","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/jop.12606","volume":"46","author":"M Kawata","year":"2017","unstructured":"Kawata M, Ogi K, Nishiyama K et al (2017) Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma. J Oral Pathol Med 46:979\u2013985. https:\/\/doi.org\/10.1111\/jop.12606","journal-title":"J Oral Pathol Med"},{"key":"10863_CR51","doi-asserted-by":"publisher","first-page":"106536","DOI":"10.1016\/j.oraloncology.2023.106536","volume":"145","author":"JO Kemnade","year":"2023","unstructured":"Kemnade JO, Florez M, Sabichi A et al (2023) Phase I \/ II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol 145:106536. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106536","journal-title":"Oral Oncol"},{"key":"10863_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/jcm8010075","volume":"8","author":"N Kindt","year":"2019","unstructured":"Kindt N, Descamps G, Lechien JR et al (2019) Involvement of HPV infection in the release of macrophage migration inhibitory factor in head and neck squamous cell carcinoma. J Clin Med 8:75. https:\/\/doi.org\/10.3390\/jcm8010075","journal-title":"J Clin Med"},{"key":"10863_CR53","doi-asserted-by":"publisher","first-page":"89681","DOI":"10.18632\/oncotarget.20813","volume":"8","author":"J Knuth","year":"2017","unstructured":"Knuth J, Sharma SJ, W\u00c3\u00bcrdemann N et al (2017) Hypoxiainducible factor1\u00ce\u00b1 activation in HPVpositive head and neck squamous cell carcinoma cell lines. Oncotarget 8:89681\u201389691. https:\/\/doi.org\/10.18632\/oncotarget.20813","journal-title":"Oncotarget"},{"key":"10863_CR54","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/ph17060744","volume":"17","author":"T Koltai","year":"2024","unstructured":"Koltai T, Fliegel L (2024) Dichloroacetate for cancer treatment: some facts and many doubts. Pharmaceuticals 17:744. https:\/\/doi.org\/10.3390\/ph17060744","journal-title":"Pharmaceuticals"},{"key":"10863_CR55","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3390\/cancers14122884","volume":"14","author":"N Kondoh","year":"2022","unstructured":"Kondoh N, Mizuno-Kamiya M (2022) The role of immune modulatory cytokines in the tumor microenvironments of head and neck squamous cell carcinomas. Cancers (Basel) 14:2884. https:\/\/doi.org\/10.3390\/cancers14122884","journal-title":"Cancers (Basel)"},{"key":"10863_CR56","doi-asserted-by":"publisher","first-page":"217320","DOI":"10.1016\/j.canlet.2024.217320","volume":"606","author":"J Korns","year":"2024","unstructured":"Korns J, Wicker CA, Lehn M et al (2024) Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma. Cancer Lett 606:217320. https:\/\/doi.org\/10.1016\/j.canlet.2024.217320","journal-title":"Cancer Lett"},{"key":"10863_CR57","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1158\/0008-5472.CAN-17-1076","volume":"78","author":"D Kumar","year":"2018","unstructured":"Kumar D, New J, Vishwakarma V et al (2018) Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression. Cancer Res 78:3769\u20133782. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1076","journal-title":"Cancer Res"},{"key":"10863_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12915-019-0669-x","volume":"17","author":"S Lagziel","year":"2019","unstructured":"Lagziel S, Lee WD, Shlomi T (2019) Studying metabolic flux adaptations in cancer through integrated experimental-computational approaches. BMC Biol 17:51. https:\/\/doi.org\/10.1186\/s12915-019-0669-x","journal-title":"BMC Biol"},{"key":"10863_CR59","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/cancers12051060","volume":"12","author":"JR Lechien","year":"2020","unstructured":"Lechien JR, Descamps G, Seminerio I et al (2020) HPV involvement in the tumor microenvironment and immune treatment in head and neck squamous cell carcinomas. Cancers (Basel) 12:1060. https:\/\/doi.org\/10.3390\/cancers12051060","journal-title":"Cancers (Basel)"},{"key":"10863_CR60","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR (2022) HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 19:306\u2013327. https:\/\/doi.org\/10.1038\/s41571-022-00603-7","journal-title":"Nat Rev Clin Oncol"},{"key":"10863_CR61","doi-asserted-by":"publisher","first-page":"e40767","DOI":"10.1371\/journal.pone.0040767","volume":"7","author":"L-A Lee","year":"2012","unstructured":"Lee L-A, Huang C-G, Liao C-T et al (2012) Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS ONE 7:e40767. https:\/\/doi.org\/10.1371\/journal.pone.0040767","journal-title":"PLoS ONE"},{"key":"10863_CR62","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/metabo9090188","volume":"9","author":"N Lee","year":"2019","unstructured":"Lee N, Jang W-J, Seo JH et al (2019) 2-Deoxy-d-glucose-induced metabolic alteration in human oral squamous SCC15 cells: involvement of N-glycosylation of Axl and Met. Metabolites 9:188. https:\/\/doi.org\/10.3390\/metabo9090188","journal-title":"Metabolites"},{"key":"10863_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrc.2018.11","volume":"18","author":"CR Leemans","year":"2018","unstructured":"Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18:269\u2013282. https:\/\/doi.org\/10.1038\/nrc.2018.11","journal-title":"Nat Rev Cancer"},{"key":"10863_CR64","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s12105-022-01467-0","volume":"16","author":"JS Lewis","year":"2022","unstructured":"Lewis JS, Smith MH, Wang X et al (2022) Human papillomavirus-associated oral cavity squamous cell carcinoma: an entity with distinct morphologic and clinical features. Head Neck Pathol 16:1073\u20131081. https:\/\/doi.org\/10.1007\/s12105-022-01467-0","journal-title":"Head Neck Pathol"},{"key":"10863_CR70","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.7150\/jca.29838","volume":"10","author":"Z Li","year":"2019","unstructured":"Li Z, Liu J, Que L, Tang X (2019) The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K\/Akt\/mTOR pathway. J Cancer 10:5770\u20135784. https:\/\/doi.org\/10.7150\/jca.29838","journal-title":"J Cancer"},{"key":"10863_CR69","doi-asserted-by":"publisher","first-page":"687245","DOI":"10.3389\/fcell.2021.687245","volume":"9","author":"S Li","year":"2021","unstructured":"Li S, Mai Z, Gu W et al (2021) Molecular subtypes of oral squamous cell carcinoma based on immunosuppression genes using a deep learning approach. Front Cell Dev Biol 9:687245. https:\/\/doi.org\/10.3389\/fcell.2021.687245","journal-title":"Front Cell Dev Biol"},{"key":"10863_CR67","doi-asserted-by":"publisher","first-page":"1304106","DOI":"10.3389\/fonc.2023.1304106","volume":"13","author":"N Li","year":"2023","unstructured":"Li N, Chamkha I, Verma G et al (2023a) Human papillomavirus-associated head and neck squamous cell carcinoma cells rely on glycolysis and display reduced oxidative phosphorylation. Front Oncol 13:1304106. https:\/\/doi.org\/10.3389\/fonc.2023.1304106","journal-title":"Front Oncol"},{"key":"10863_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","volume":"8","author":"Q Li","year":"2023","unstructured":"Li Q, Tie Y, Alu A et al (2023b) Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Sig Transduct Target Ther 8:31. https:\/\/doi.org\/10.1038\/s41392-022-01297-0","journal-title":"Sig Transduct Target Ther"},{"key":"10863_CR66","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/cancers16173017","volume":"16","author":"J-H Li","year":"2024","unstructured":"Li J-H, Hsin P-Y, Hsiao Y-C et al (2024) A narrative review: repurposing metformin as a potential therapeutic agent for oral cancer. Cancers 16:3017. https:\/\/doi.org\/10.3390\/cancers16173017","journal-title":"Cancers"},{"key":"10863_CR65","doi-asserted-by":"publisher","first-page":"101607","DOI":"10.1016\/j.gendis.2025.101607","volume":"12","author":"H Li","year":"2025","unstructured":"Li H, Peng Q, Oyang L et al (2025) The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer. Genes Dis 12:101607. https:\/\/doi.org\/10.1016\/j.gendis.2025.101607","journal-title":"Genes Dis"},{"key":"10863_CR71","doi-asserted-by":"publisher","first-page":"1271505","DOI":"10.3389\/fonc.2023.1271505","volume":"13","author":"J Liang","year":"2023","unstructured":"Liang J, Li L, Li L et al (2023) Lipid metabolism reprogramming in head and neck cancer. Front Oncol 13:1271505. https:\/\/doi.org\/10.3389\/fonc.2023.1271505","journal-title":"Front Oncol"},{"key":"10863_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40463-017-0185-3","volume":"46","author":"C Lindsay","year":"2017","unstructured":"Lindsay C, Seikaly H, Biron VL (2017) Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets. J Otolaryngol Head Neck Surg 46:9. https:\/\/doi.org\/10.1186\/s40463-017-0185-3","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10863_CR75","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12903-022-02358-0","volume":"22","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang T, Li R (2022) A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes. BMC Oral Health 22:324. https:\/\/doi.org\/10.1186\/s12903-022-02358-0","journal-title":"BMC Oral Health"},{"key":"10863_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41368-023-00267-8","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang Z, Zhang Y et al (2024) Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma. Int J Oral Sci 16:9. https:\/\/doi.org\/10.1038\/s41368-023-00267-8","journal-title":"Int J Oral Sci"},{"key":"10863_CR73","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41698-025-01132-z","volume":"9","author":"G Liu","year":"2025","unstructured":"Liu G, Yao X, Hou Y et al (2025a) Metabolomic and transcriptomic profiling of HNSCC identifies AMIGO2 as a therapeutic target modulating tumor microenvironment. NPJ Precis Oncol 9:358. https:\/\/doi.org\/10.1038\/s41698-025-01132-z","journal-title":"NPJ Precis Oncol"},{"key":"10863_CR74","doi-asserted-by":"publisher","unstructured":"Liu X, Harbison RA, Varvares MA et al (2025b) Immunotherapeutic strategies in head and neck cancer: challenges and opportunities. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI188128","DOI":"10.1172\/JCI188128"},{"key":"10863_CR77","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1002\/cam4.2965","volume":"9","author":"Y Luo","year":"2020","unstructured":"Luo Y, Li W, Ling Z et al (2020) ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells. Cancer Med 9:3489\u20133499. https:\/\/doi.org\/10.1002\/cam4.2965","journal-title":"Cancer Med"},{"key":"10863_CR78","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1158\/1940-6207.CAPR-14-0348","volume":"8","author":"D Madera","year":"2015","unstructured":"Madera D, Vitale-Cross L, Martin D et al (2015) Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. Cancer Prev Res (Phila) 8:197\u2013207. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0348","journal-title":"Cancer Prev Res (Phila)"},{"key":"10863_CR79","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/jcm13185632","volume":"13","author":"A Mamilos","year":"2024","unstructured":"Mamilos A, Winter L, Lein A et al (2024) Metformin treatment is not associated with altered PD-L1 expression in diabetic patients with oral squamous cell carcinoma. J Clin Med 13:5632. https:\/\/doi.org\/10.3390\/jcm13185632","journal-title":"J Clin Med"},{"key":"10863_CR80","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1186\/s12967-025-07280-x","volume":"23","author":"E Markovits","year":"2025","unstructured":"Markovits E, Klymyshyn D, Froumine R et al (2025) Spatial profiling of HPV-stratified head and neck squamous cell carcinoma reveals distinct immune niches and microenvironmental architectures. J Transl Med 23:1304. https:\/\/doi.org\/10.1186\/s12967-025-07280-x","journal-title":"J Transl Med"},{"key":"10863_CR81","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/ijms19071839","volume":"19","author":"I Mart\u00ednez-Ram\u00edrez","year":"2018","unstructured":"Mart\u00ednez-Ram\u00edrez I, Carrillo-Garc\u00eda A, Contreras-Paredes A et al (2018) Regulation of cellular metabolism by high-risk human papillomaviruses. Int J Mol Sci 19:1839. https:\/\/doi.org\/10.3390\/ijms19071839","journal-title":"Int J Mol Sci"},{"key":"10863_CR82","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15252\/emmm.201404271","volume":"7","author":"A McIntyre","year":"2015","unstructured":"McIntyre A, Harris AL (2015) Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality. EMBO Mol Med 7:368\u2013379. https:\/\/doi.org\/10.15252\/emmm.201404271","journal-title":"EMBO Mol Med"},{"key":"10863_CR83","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41419-023-06248-3","volume":"14","author":"A Medda","year":"2023","unstructured":"Medda A, Compagnoni M, Spini G et al (2023) c-MYC-dependent transcriptional inhibition of autophagy is implicated in cisplatin sensitivity in HPV-positive head and neck cancer. Cell Death Dis 14:719. https:\/\/doi.org\/10.1038\/s41419-023-06248-3","journal-title":"Cell Death Dis"},{"key":"10863_CR84","doi-asserted-by":"publisher","first-page":"16804","DOI":"10.1038\/s41598-018-35103-1","volume":"8","author":"M Mehibel","year":"2018","unstructured":"Mehibel M, Ortiz-Martinez F, Voelxen N et al (2018) Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters. Sci Rep 8:16804. https:\/\/doi.org\/10.1038\/s41598-018-35103-1","journal-title":"Sci Rep"},{"key":"10863_CR85","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1097\/RLU.0000000000001578","volume":"42","author":"E Mena","year":"2017","unstructured":"Mena E, Taghipour M, Sheikhbahaei S et al (2017) Value of intra-tumoral metabolic heterogeneity and quantitative 18F-FDG PET\/CT parameters to predict prognosis, in patients with HPV-positive primary oropharyngeal squamous cell carcinoma. Clin Nucl Med 42:e227\u2013e234. https:\/\/doi.org\/10.1097\/RLU.0000000000001578","journal-title":"Clin Nucl Med"},{"key":"10863_CR86","doi-asserted-by":"publisher","first-page":"1008361","DOI":"10.3389\/fonc.2022.1008361","volume":"12","author":"X Miao","year":"2022","unstructured":"Miao X, Wang B, Chen K et al (2022) Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: an overview. Front Oncol 12:1008361. https:\/\/doi.org\/10.3389\/fonc.2022.1008361","journal-title":"Front Oncol"},{"key":"10863_CR87","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12967-023-04221-4","volume":"21","author":"Z Modic","year":"2023","unstructured":"Modic Z, Cemazar M, Markelc B et al (2023) HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies. J Transl Med 21:376. https:\/\/doi.org\/10.1186\/s12967-023-04221-4","journal-title":"J Transl Med"},{"key":"10863_CR88","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550\u2013560. https:\/\/doi.org\/10.1038\/nrc2886","journal-title":"Nat Rev Cancer"},{"key":"10863_CR89","doi-asserted-by":"publisher","first-page":"e002614","DOI":"10.1136\/jitc-2021-002614","volume":"9","author":"LE Munoz","year":"2021","unstructured":"Munoz LE, Huang L, Bommireddy R et al (2021) Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy. J Immunother Cancer 9:e002614. https:\/\/doi.org\/10.1136\/jitc-2021-002614","journal-title":"J Immunother Cancer"},{"key":"10863_CR90","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/cells13131107","volume":"13","author":"JO Mu\u00f1oz-Bello","year":"2024","unstructured":"Mu\u00f1oz-Bello JO, Romero-C\u00f3rdoba SL, Garc\u00eda-Ch\u00e1vez JN et al (2024) Potential transcript-based biomarkers predicting clinical outcomes of HPV-positive head and neck squamous cell carcinoma patients. Cells 13:1107. https:\/\/doi.org\/10.3390\/cells13131107","journal-title":"Cells"},{"key":"10863_CR91","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41416-022-01848-w","volume":"127","author":"RA Noble","year":"2022","unstructured":"Noble RA, Thomas H, Zhao Y et al (2022) Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma. Br J Cancer 127:937\u2013947. https:\/\/doi.org\/10.1038\/s41416-022-01848-w","journal-title":"Br J Cancer"},{"key":"10863_CR92","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/jcm12093264","volume":"12","author":"L Nokovitch","year":"2023","unstructured":"Nokovitch L, Maquet C, Crampon F et al (2023) Oral cavity squamous cell carcinoma risk factors: state of the art. J Clin Med 12:3264. https:\/\/doi.org\/10.3390\/jcm12093264","journal-title":"J Clin Med"},{"key":"10863_CR95","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","volume":"17","author":"B O\u2019Sullivan","year":"2016","unstructured":"O\u2019Sullivan B, Huang SH, Su J et al (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 17:440\u2013451. https:\/\/doi.org\/10.1016\/S1470-2045(15)00560-4","journal-title":"Lancet Oncol"},{"key":"10863_CR93","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/ijc.28114","volume":"133","author":"T Ohashi","year":"2013","unstructured":"Ohashi T, Akazawa T, Aoki M et al (2013) Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity. Int J Cancer 133:1107\u20131118. https:\/\/doi.org\/10.1002\/ijc.28114","journal-title":"Int J Cancer"},{"key":"10863_CR94","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/v15020324","volume":"15","author":"Y Ortiz-Pedraza","year":"2023","unstructured":"Ortiz-Pedraza Y, Mu\u00f1oz-Bello JO, Ramos-Ch\u00e1vez LA et al (2023) HPV16 E6 and E7 oncoproteins stimulate the glutamine pathway maintaining cell proliferation in a SNAT1-dependent fashion. Viruses 15:324. https:\/\/doi.org\/10.3390\/v15020324","journal-title":"Viruses"},{"key":"10863_CR96","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/lary.28441","volume":"130","author":"TJ Ow","year":"2020","unstructured":"Ow TJ, Thomas C, Fulcher CD et al (2020) Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma. Laryngoscope 130:2643\u20132649. https:\/\/doi.org\/10.1002\/lary.28441","journal-title":"Laryngoscope"},{"key":"10863_CR97","doi-asserted-by":"publisher","first-page":"404","DOI":"10.32074\/1591-951X-1085","volume":"116","author":"M Palazzo","year":"2024","unstructured":"Palazzo M, Novizio N, Belvedere R et al (2024) Metformin radiosensitizes OSCC in 2D and 3D models: possible involvement of CAF-1. Pathologica 116:404\u2013416. https:\/\/doi.org\/10.32074\/1591-951X-1085","journal-title":"Pathologica"},{"key":"10863_CR98","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3343\/alm.2023.0443","volume":"44","author":"SH Park","year":"2024","unstructured":"Park SH, Lee J, Yun HJ et al (2024) Metformin suppresses Both PD-L1 expression in cancer cells and cancer-induced PD-1 expression in immune cells to promote antitumor immunity. Ann Lab Med 44:426\u2013436. https:\/\/doi.org\/10.3343\/alm.2023.0443","journal-title":"Ann Lab Med"},{"key":"10863_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0973-029X.131945","volume":"18","author":"J Pathak","year":"2014","unstructured":"Pathak J, Swain N, Patel S, Poonja L (2014) Histopathological variants of oral squamous cell carcinoma-institutional case reports. J Oral Maxillofac Pathol 18:143\u2013145. https:\/\/doi.org\/10.4103\/0973-029X.131945","journal-title":"J Oral Maxillofac Pathol"},{"key":"10863_CR100","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/1471-2407-14-751","volume":"14","author":"C Pinheiro","year":"2014","unstructured":"Pinheiro C, Garcia EA, Morais-Santos F et al (2014) Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer 14:751. https:\/\/doi.org\/10.1186\/1471-2407-14-751","journal-title":"BMC Cancer"},{"key":"10863_CR101","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10637-022-01235-5","volume":"40","author":"SF Powell","year":"2022","unstructured":"Powell SF, Mazurczak M, Dib EG et al (2022) Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma. Invest New Drugs 40:622\u2013633. https:\/\/doi.org\/10.1007\/s10637-022-01235-5","journal-title":"Invest New Drugs"},{"key":"10863_CR103","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/cancers12010253","volume":"12","author":"MA Prusinkiewicz","year":"2020","unstructured":"Prusinkiewicz MA, Gameiro SF, Ghasemi F et al (2020) Survival-associated metabolic genes in human papillomavirus-positive head and neck cancers. Cancers (Basel) 12:253. https:\/\/doi.org\/10.3390\/cancers12010253","journal-title":"Cancers (Basel)"},{"key":"10863_CR102","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41588-023-01357-3","volume":"55","author":"SV Puram","year":"2023","unstructured":"Puram SV, Mints M, Pal A et al (2023) Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma. Nat Genet 55:640\u2013650. https:\/\/doi.org\/10.1038\/s41588-023-01357-3","journal-title":"Nat Genet"},{"key":"10863_CR104","doi-asserted-by":"publisher","first-page":"35788","DOI":"10.1038\/srep35788","volume":"6","author":"X Qi","year":"2016","unstructured":"Qi X, Xu W, Xie J et al (2016) Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-\u03baB\/HIF-1\u03b1 signal axis. Sci Rep 6:35788. https:\/\/doi.org\/10.1038\/srep35788","journal-title":"Sci Rep"},{"key":"10863_CR105","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejca.2016.06.006","volume":"65","author":"G Qian","year":"2016","unstructured":"Qian G, Wang D, Magliocca KR et al (2016) Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation. Eur J Cancer 65:21\u201332. https:\/\/doi.org\/10.1016\/j.ejca.2016.06.006","journal-title":"Eur J Cancer"},{"key":"10863_CR106","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","volume":"71","author":"LE Raez","year":"2013","unstructured":"Raez LE, Papadopoulos K, Ricart AD et al (2013) A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol 71:523\u2013530. https:\/\/doi.org\/10.1007\/s00280-012-2045-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"10863_CR107","doi-asserted-by":"publisher","unstructured":"Rajneesh, Tiwari R, Singh VK et al (2025) Exploring metabolic and immunological biomarkers for oral squamous cell carcinoma: potential targets for precision therapy. Biology 14:1109. https:\/\/doi.org\/10.3390\/biology14091109","DOI":"10.3390\/biology14091109"},{"key":"10863_CR108","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-021-03474-5","volume":"12","author":"M Raudensk\u00e1","year":"2021","unstructured":"Raudensk\u00e1 M, Balvan J, Masa\u0159\u00edk M (2021) Cell death in head and neck cancer pathogenesis and treatment. Cell Death Dis 12:192. https:\/\/doi.org\/10.1038\/s41419-021-03474-5","journal-title":"Cell Death Dis"},{"key":"10863_CR109","doi-asserted-by":"publisher","first-page":"S691","DOI":"10.1016\/j.annonc.2024.08.1081","volume":"35","author":"JW Riess","year":"2024","unstructured":"Riess JW, Spicer J, Seiwert T et al (2024) 1022P A phase II trial of the IO102-IO103 vaccine plus pembrolizumab: completed cohort for first-line (1L) treatment of advanced squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol 35:S691. https:\/\/doi.org\/10.1016\/j.annonc.2024.08.1081","journal-title":"Ann Oncol"},{"key":"10863_CR110","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-9378-6-18","volume":"6","author":"V Rodolico","year":"2011","unstructured":"Rodolico V, Arancio W, Amato MC et al (2011) Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. Infect Agent Cancer 6:18. https:\/\/doi.org\/10.1186\/1750-9378-6-18","journal-title":"Infect Agent Cancer"},{"key":"10863_CR111","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2015.11.023","volume":"371","author":"J-L Roh","year":"2016","unstructured":"Roh J-L, Park JY, Kim EH et al (2016) Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Cancer Lett 371:20\u201329. https:\/\/doi.org\/10.1016\/j.canlet.2015.11.023","journal-title":"Cancer Lett"},{"key":"10863_CR112","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/PAS.0000000000001433","volume":"44","author":"LM Rooper","year":"2020","unstructured":"Rooper LM, Windon MJ, Hernandez T et al (2020) HPV-positive squamous cell carcinoma of the larynx, oral cavity, and hypopharynx: clinicopathologic characterization with recognition of a novel warty variant. Am J Surg Pathol 44:691\u2013702. https:\/\/doi.org\/10.1097\/PAS.0000000000001433","journal-title":"Am J Surg Pathol"},{"key":"10863_CR113","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12885-021-09151-2","volume":"22","author":"H Rostamian","year":"2022","unstructured":"Rostamian H, Khakpoor-Koosheh M, Jafarzadeh L et al (2022) Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions. BMC Cancer 22:39. https:\/\/doi.org\/10.1186\/s12885-021-09151-2","journal-title":"BMC Cancer"},{"key":"10863_CR114","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ijc.32688","volume":"146","author":"J Sadri Nahand","year":"2020","unstructured":"Sadri Nahand J, Moghoofei M, Salmaninejad A et al (2020) Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review. Int J Cancer 146:305\u2013320. https:\/\/doi.org\/10.1002\/ijc.32688","journal-title":"Int J Cancer"},{"key":"10863_CR115","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.3390\/cancers12123788","volume":"12","author":"P Saggese","year":"2020","unstructured":"Saggese P, Sellitto A, Martinez CA et al (2020) Metabolic regulation of epigenetic modifications and cell differentiation in cancer. Cancers (Basel) 12:3788. https:\/\/doi.org\/10.3390\/cancers12123788","journal-title":"Cancers (Basel)"},{"key":"10863_CR116","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/cncr.25868","volume":"117","author":"VC Sandulache","year":"2011","unstructured":"Sandulache VC, Ow TJ, Pickering CR et al (2011) Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer 117:2926\u20132938. https:\/\/doi.org\/10.1002\/cncr.25868","journal-title":"Cancer"},{"key":"10863_CR117","doi-asserted-by":"publisher","first-page":"e159600","DOI":"10.1172\/jci.insight.159600","volume":"7","author":"MK Sannigrahi","year":"2022","unstructured":"Sannigrahi MK, Rajagopalan P, Lai L et al (2022) HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1\u03b1\/ERR\u03b1 axis. JCI Insight 7:e159600. https:\/\/doi.org\/10.1172\/jci.insight.159600","journal-title":"JCI Insight"},{"key":"10863_CR118","doi-asserted-by":"publisher","first-page":"42714","DOI":"10.1038\/s41598-025-26690-x","volume":"15","author":"KA Shen","year":"2025","unstructured":"Shen KA, Lee J-J, Cheng S-Y et al (2025) Enhanced glycolysis and nicotinamide metabolism in HPV-positive head and neck cancer. Sci Rep 15:42714. https:\/\/doi.org\/10.1038\/s41598-025-26690-x","journal-title":"Sci Rep"},{"key":"10863_CR119","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-06-3717","volume":"67","author":"AL Simons","year":"2007","unstructured":"Simons AL, Ahmad IM, Mattson DM et al (2007) 2-deoxy-d-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 67:3364\u20133370. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3717","journal-title":"Cancer Res"},{"key":"10863_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3727\/096504016X14586627440192","volume":"24","author":"A Sobhakumari","year":"2016","unstructured":"Sobhakumari A, Orcutt KP, Love-Homan L et al (2016) 2-deoxy-d-glucose suppresses the in vivo antitumor efficacy of erlotinib in head and neck squamous cell carcinoma cells. Oncol Res 24:55\u201364. https:\/\/doi.org\/10.3727\/096504016X14586627440192","journal-title":"Oncol Res"},{"key":"10863_CR121","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P (2022) Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell 13:877\u2013919. https:\/\/doi.org\/10.1007\/s13238-021-00846-7","journal-title":"Protein Cell"},{"key":"10863_CR122","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.ijrobp.2021.12.083","volume":"112","author":"S Sussman","year":"2022","unstructured":"Sussman S, Linnenbach A, Harshyne L et al (2022) Differential activation of cancer-associated fibroblasts in HPV-associated head and neck squamous cell carcinoma patients detected using spatial transcriptomics. Int J Radiation Oncology*Biology*Physics 112:e35\u2013e36. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.12.083","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"10863_CR123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M et al (2023) Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci 15:44. https:\/\/doi.org\/10.1038\/s41368-023-00249-w","journal-title":"Int J Oral Sci"},{"key":"10863_CR124","doi-asserted-by":"publisher","first-page":"8201079","DOI":"10.1155\/2019\/8201079","volume":"2019","author":"T Tataranni","year":"2019","unstructured":"Tataranni T, Piccoli C (2019) Dichloroacetate (DCA) and cancer: an overview towards clinical applications. Oxid Med Cell Longev 2019:8201079. https:\/\/doi.org\/10.1155\/2019\/8201079","journal-title":"Oxid Med Cell Longev"},{"key":"10863_CR23","doi-asserted-by":"publisher","DOI":"10.21037\/ajo.2019.01.01","author":"A Taylor","year":"2019","unstructured":"Taylor A, Eade T, Veivers D et al (2019) Human papillomavirus and oropharyngeal squamous cell carcinoma: a 12-year retrospective review in a New South Wales tertiary referral centre. Australian J Otolaryngol 2. https:\/\/doi.org\/10.21037\/ajo.2019.01.01","journal-title":"Australian J Otolaryngol 2"},{"key":"10863_CR125","unstructured":"Thomas Jefferson University (2025) Window-of-Opportunity Trial of Nivolumab and BMS986205 in Patients With Squamous Cell Carcinoma of the Head and Neck (CA017\u2013087). clinicaltrials.gov"},{"key":"10863_CR126","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s41467-025-56675-3","volume":"16","author":"V Van den Bossche","year":"2025","unstructured":"Van den Bossche V, Vignau J, Vigneron E et al (2025) PPAR\u03b1-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma. Nat Commun 16:1237. https:\/\/doi.org\/10.1038\/s41467-025-56675-3","journal-title":"Nat Commun"},{"key":"10863_CR127","doi-asserted-by":"publisher","first-page":"e176736","DOI":"10.1172\/JCI176736","volume":"134","author":"K Vasan","year":"2024","unstructured":"Vasan K, Chandel NS (2024) Molecular and cellular mechanisms underlying the failure of mitochondrial metabolism drugs in cancer clinical trials. J Clin Invest 134:e176736. https:\/\/doi.org\/10.1172\/JCI176736","journal-title":"J Clin Invest"},{"key":"10863_CR128","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.18632\/oncotarget.27348","volume":"11","author":"AK Verma","year":"2020","unstructured":"Verma AK, Messerli SM, Miskimins WK (2020) Lactate induces PD-L1 in HRASG12V-positive oropharyngeal squamous cell carcinoma. Oncotarget 11:1493\u20131504. https:\/\/doi.org\/10.18632\/oncotarget.27348","journal-title":"Oncotarget"},{"key":"10863_CR129","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-20-4789","volume":"27","author":"A Vyas","year":"2021","unstructured":"Vyas A, Harbison RA, Faden DL et al (2021) Recurrent human papillomavirus-related head and neck cancer undergoes metabolic reprogramming and is driven by oxidative phosphorylation. Clin Cancer Res 27:6250\u20136264. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4789","journal-title":"Clin Cancer Res"},{"key":"10863_CR131","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fonc.2019.01084","volume":"9","author":"H-C Wang","year":"2019","unstructured":"Wang H-C, Chan L-P, Cho S-F (2019) Targeting the immune microenvironment in the treatment of head and neck squamous cell carcinoma. Front Oncol 9:1084. https:\/\/doi.org\/10.3389\/fonc.2019.01084","journal-title":"Front Oncol"},{"key":"10863_CR130","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/cas.15281","volume":"113","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang S, Tong F et al (2022) HPV+ HNSCC-derived exosomal miR-9-5p inhibits TGF-\u03b2 signaling-mediated fibroblast phenotypic transformation through NOX4. Cancer Sci 113:1475\u20131487. https:\/\/doi.org\/10.1111\/cas.15281","journal-title":"Cancer Sci"},{"key":"10863_CR132","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijms252212223","volume":"25","author":"J Wang","year":"2024","unstructured":"Wang J, He Y, Hu F et al (2024) Metabolic reprogramming of immune cells in the tumor microenvironment. Int J Mol Sci 25:12223. https:\/\/doi.org\/10.3390\/ijms252212223","journal-title":"Int J Mol Sci"},{"key":"10863_CR133","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2020.12.038","volume":"502","author":"CA Wicker","year":"2021","unstructured":"Wicker CA, Hunt BG, Krishnan S et al (2021) Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. Cancer Lett 502:180\u2013188. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.038","journal-title":"Cancer Lett"},{"key":"10863_CR134","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.3390\/cancers13194836","volume":"13","author":"MD Wilkie","year":"2021","unstructured":"Wilkie MD, Anaam EA, Lau AS et al (2021) Metabolic plasticity and combinatorial radiosensitisation strategies in human papillomavirus-positive squamous cell carcinoma of the head and neck cell lines. Cancers 13:4836. https:\/\/doi.org\/10.3390\/cancers13194836","journal-title":"Cancers"},{"key":"10863_CR135","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3892\/ijmm.2017.3267","volume":"41","author":"J Wu","year":"2018","unstructured":"Wu J, Hong Y, Wu T et al (2018) Stromal-epithelial lactate shuttle induced by tumor-derived interleukin-1\u03b2 promotes cell proliferation in oral squamous cell carcinoma. Int J Mol Med 41:687\u2013696. https:\/\/doi.org\/10.3892\/ijmm.2017.3267","journal-title":"Int J Mol Med"},{"key":"10863_CR137","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1158\/0008-5472.CAN-18-3525","volume":"79","author":"X Wu","year":"2019","unstructured":"Wu X, Yeerna H, Goto Y et al (2019) Metformin inhibits progression of head and neck squamous cell carcinoma by acting directly on carcinoma initiating cells. Cancer Res 79:4360\u20134370. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3525","journal-title":"Cancer Res"},{"key":"10863_CR136","doi-asserted-by":"publisher","first-page":"e44295","DOI":"10.1097\/MD.0000000000044295","volume":"104","author":"X Wu","year":"2025","unstructured":"Wu X, Shang M, Li M et al (2025) Advances in the therapeutic applications of dichloroacetate as a metabolic regulator: a review. Medicine 104:e44295. https:\/\/doi.org\/10.1097\/MD.0000000000044295","journal-title":"Medicine"},{"key":"10863_CR138","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2012.00163","volume":"2","author":"J Yun","year":"2012","unstructured":"Yun J, Johnson JL, Hanigan CL, Locasale JW (2012) Interactions between epigenetics and metabolism in cancers. Front Oncol 2:163. https:\/\/doi.org\/10.3389\/fonc.2012.00163","journal-title":"Front Oncol"},{"key":"10863_CR139","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/diagnostics15172262","volume":"15","author":"RN Zalzal","year":"2025","unstructured":"Zalzal RN, Fakhruddin N, Mahfouz R (2025) Liquid biopsy\u2019s role in head and neck tumors: changing paradigms in the era of precision medicine. Diagnostics (Basel) 15:2262. https:\/\/doi.org\/10.3390\/diagnostics15172262","journal-title":"Diagnostics (Basel)"},{"key":"10863_CR142","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1593\/neo.131400","volume":"15","author":"XC Zhang","year":"2013","unstructured":"Zhang XC, Xu C, Mitchell RM et al (2013) Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole-genome sequencing. Neoplasia 15:1371\u20131378. https:\/\/doi.org\/10.1593\/neo.131400","journal-title":"Neoplasia"},{"key":"10863_CR140","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wu J, Ling MT et al (2015) The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer 14:87. https:\/\/doi.org\/10.1186\/s12943-015-0361-x","journal-title":"Mol Cancer"},{"key":"10863_CR144","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00018-019-03209-y","volume":"77","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Gao Z, Rajthala S et al (2020a) Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts. Cell Mol Life Sci 77:1115\u20131133. https:\/\/doi.org\/10.1007\/s00018-019-03209-y","journal-title":"Cell Mol Life Sci"},{"key":"10863_CR145","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41416-019-0637-9","volume":"122","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Liu R, Shuai Y et al (2020b) ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. Br J Cancer 122:82\u201393. https:\/\/doi.org\/10.1038\/s41416-019-0637-9","journal-title":"Br J Cancer"},{"key":"10863_CR141","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/CAD.0000000000001711","volume":"36","author":"R Zhang","year":"2025","unstructured":"Zhang R, Hou F, Gan J et al (2025a) Metformin-induced E6\/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation. Anticancer Drugs 36:468\u2013477. https:\/\/doi.org\/10.1097\/CAD.0000000000001711","journal-title":"Anticancer Drugs"},{"key":"10863_CR143","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","volume":"10","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qiu K, Ren J et al (2025b) Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. Signal Transduct Target Ther 10:44. https:\/\/doi.org\/10.1038\/s41392-024-02083-w","journal-title":"Signal Transduct Target Ther"},{"key":"10863_CR146","doi-asserted-by":"publisher","first-page":"1371365","DOI":"10.3389\/fimmu.2024.1371365","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yu J, Zheng C, Zhou B (2024) Establishment of a prognostic model for hypoxia-associated genes in OPSCC and revelation of intercellular crosstalk. Front Immunol 15:1371365. https:\/\/doi.org\/10.3389\/fimmu.2024.1371365","journal-title":"Front Immunol"},{"key":"10863_CR147","doi-asserted-by":"publisher","first-page":"P35","DOI":"10.1186\/1750-9378-7-S1-P35","volume":"7","author":"C Zhuang","year":"2012","unstructured":"Zhuang C, Yuh-Seog Jung DV, Haugrud A et al (2012) HPV+ cancer cell lactate production attenuates immune response during treatment: lactate production inhibition leads to improved long-term cures. Infect Agents Cancer 7:P35. https:\/\/doi.org\/10.1186\/1750-9378-7-S1-P35","journal-title":"Infect Agents Cancer"},{"key":"10863_CR148","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/cancers16081525","volume":"16","author":"Y Zhuang","year":"2024","unstructured":"Zhuang Y, Coppock JD, Haugrud AB et al (2024) Dichloroacetate and quercetin prevent cell proliferation, induce cell death and slow tumor growth in a mouse model of HPV-positive head and neck cancer. Cancers (Basel) 16:1525. https:\/\/doi.org\/10.3390\/cancers16081525","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10863-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10863-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10863-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:49:23Z","timestamp":1786949363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10863-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":149,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10863"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10863-7","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this study did not involve human or animal subjects and therefore did not require ethical approval or informed consent.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, since no person\u2019s data are included in this study.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted technologies were used only to improve clarity and readability of language. They were not used for content generation, data analysis, or interpretation. All scientific content, results, and conclusions are the authors\u2019 original work. The authors reviewed and approved all content before submission to ensure accuracy and compliance with journal policies.","order":4,"name":"Ethics","label":"AI declaration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"212"}}